Ftse Mib
34.165,92
0,01%
DAX
19.909,14
-0,25%
S&P 500
5.935,07
-0,60%
NASDAQ
19.601,15
-0,61%
Bitcoin
94.320,39
0,86%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ANI Pharmaceuticals Inc (ANIP) ANI Pharmaceuticals Inc (ANIP) Notizie

ANI Pharmaceuticals Inc

ANIP
53,49
-0,92 (-1,69%)
Ultimo aggiornamento: 19:14:39
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:35EDGAR2Form 144 - Report of proposed sale of securities
16/12/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202401:44EDGAR2Form 144 - Report of proposed sale of securities
26/11/202422:30GLOBEANI Pharmaceuticals to Present at 36th Annual Piper Sandler..
20/11/202413:00EDGAR2Form 8-K - Current report
18/11/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202412:55EDGAR2Form 8-K - Current report
08/11/202412:50GLOBEANI Pharmaceuticals Reports Record Third Quarter 2024..
04/11/202422:30GLOBEANI Pharmaceuticals to Present at Guggenheim's Inaugural..
30/10/202422:00GLOBEANI Pharmaceuticals to Discuss Third Quarter 2024 Financial..
25/10/202412:50GLOBEANI Pharmaceuticals Announces the FDA Approval and Launch of..
24/10/202412:50GLOBEANI Pharmaceuticals to Present New Data Highlighting..
15/10/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202412:50GLOBEANI Pharmaceuticals Announces the FDA Approval and Launch of..
20/9/202422:03EDGAR2Form 8-K - Current report
16/9/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202415:13EDGAR2Form 8-K - Current report
16/9/202414:53GLOBEANI Pharmaceuticals, Inc. Completes Acquisition of Alimera..
16/9/202412:50GLOBEANI Pharmaceuticals Initiates Closing of Acquisition of..
13/9/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202412:50GLOBEANI Pharmaceuticals Launches Promethazine Hydrochloride and..
11/9/202412:50BWANI Pharmaceuticals and Alimera Sciences Announce Closing..
10/9/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202420:09GLOBEANI Pharmaceuticals Provides Update on Closing of..
14/8/202414:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:21EDGAR2Form 8-K - Current report
13/8/202422:05GLOBEANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible..
08/8/202403:51EDGAR2Form 8-K - Current report
08/8/202403:44GLOBEANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million..
07/8/202413:26EDGAR2Form 8-K - Current report
07/8/202413:00GLOBEANI Pharmaceuticals, Inc. Announces Proposed Convertible..
06/8/202412:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202412:53EDGAR2Form 8-K - Current report
06/8/202412:50GLOBEANI Pharmaceuticals Reports Second Quarter 2024 Financial..
31/7/202413:00GLOBEANI Pharmaceuticals to Discuss Second Quarter 2024 Financial..
19/7/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202423:12EDGAR2Form 144 - Report of proposed sale of securities
18/7/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202422:41EDGAR2Form 144 - Report of proposed sale of securities
16/7/202423:37EDGAR2Form 144 - Report of proposed sale of securities
15/7/202422:57EDGAR2Form 144 - Report of proposed sale of securities
15/7/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 54,01 Min: 53,15 Max: 54,40
Chiusura: 54,41

La tua Cronologia

NASDAQ
ANIP
ANI Pharmaceuticals
NASDAQ
SMLR
Semier Scientific
LSE
0J11
Grubhub
BIT
NSCIT1218808
International Bank for R...
BIT
NSCIT5532931
Koromo Italy
BIT
NSCIT00769G0
KFW
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network